Anthropic shows Claude can run an entire protein design pipeline

Anthropic had Claude models autonomously steer existing specialized tools to design small proteins that dock onto target structures in the body, a key early step in drug development. The models reached hit rates up to 35%, compared with a 10-15% industry average, though Claude directed existing tools rather than designing proteins from scratch, and independent review is still pending.

Why it matters: This extends the trend of large language model (LLM) agents orchestrating specialized scientific tools rather than replacing them outright, following similar agentic pushes in coding and chip-kernel design like ByteDance and Tsinghua's RL agent for GPU kernels. If the hit-rate improvement holds under independent review, it could meaningfully lower the cost of early-stage drug discovery.